PATHOLOGICAL ANGIOGENESIS IN VASCULAR TUMORS IS DRIVEN BY AKT1 AND INHIBITED BY TOPICAL RAPAMYCIN

被引：0
作者：
Phung, Thuy L. [1 ]
Antonello, Zeus [1 ]
Gerald, Damien [1 ]
Perruzzi, Carole [1 ]
Rocuts, Alexander [1 ]
Hochman, Marcelo [2 ]
Cunningham, Michael [3 ]
Mihm, Martin [4 ]
Benjamin, Laura E. [1 ]
机构：
[1] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[2] Hemangioma Int Treatment Ctr, Charlotte, SC USA
[3] Massachusetts Eye & Ear Infirm, Boston, MA 02114 USA
[4] Massachusetts Gen Hosp, Boston, MA 02114 USA
来源：
FASEB JOURNAL | 2009年 / 23卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
634.13
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Vascular leakage caused by loss of Akt1 is associated with impaired mural cell coverage
    Ha, Jung Min
    Jin, Seo Yeon
    Lee, Hye Sun
    Vafaeinik, Farzaneh
    Jung, Yoo Jin
    Keum, Hye Jin
    Song, Sang Heon
    Lee, Dong Hyung
    Kim, Chi Dae
    Bae, Sun Sik
    [J]. FEBS OPEN BIO, 2019, 9 (04): : 801 - 813
  • [42] AKT1 overexpression in endothelial cells leads to the development of cutaneous vascular malformations in vivo
    Perry, Betsy
    Banyard, Jacqueline
    McLaughlin, Elizabeth R.
    Watnick, Randy
    Sohn, Allie
    Brindley, David N.
    Obata, Toshiyuki
    Cantley, Lewis C.
    Cohen, Cynthia
    Arbiser, Jack L.
    [J]. ARCHIVES OF DERMATOLOGY, 2007, 143 (04) : 504 - 506
  • [43] Akt1/PKB upregulation leads to vascular smooth muscle cell hypertrophy and polyploidization
    Hixon, ML
    Muro-Cacho, C
    Wagner, MW
    Obejero-Paz, C
    Millie, E
    Fujio, Y
    Kureishi, Y
    Hassold, T
    Walsh, K
    Gualberto, A
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2000, 106 (08) : 1011 - 1020
  • [44] Vascular Permeability and Pathological Angiogenesis in Caveolin-1-Null Mice
    Chang, Sung-Hee
    Feng, Dian
    Nagy, Janice A.
    Sciuto, Tracey E.
    Dvorak, Ann M.
    Dvorak, Harold F.
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2009, 175 (04) : 1768 - 1776
  • [45] Regulation of angiogenesis and tumor growth by p110 alpha and AKT1 via VEGF expression
    Xia, Chang
    Meng, Qiao
    Ca, Zongxian
    Shi, Xianglin
    Jiang, Bing-Hua
    [J]. JOURNAL OF CELLULAR PHYSIOLOGY, 2006, 209 (01) : 56 - 66
  • [46] Akt activation by PHLPP1 ablation prevents pathological hypertrophy by promoting angiogenesis
    Li, Mingchuan
    Hirsch, Emilio
    [J]. CARDIOVASCULAR RESEARCH, 2015, 105 (02) : 129 - 130
  • [47] Selective activation of Akt1 by mammalian target of rapamycin complex 2 regulates cancer cell migration, invasion, and metastasis
    E K Kim
    S J Yun
    J M Ha
    Y W Kim
    I H Jin
    J Yun
    H K Shin
    S H Song
    J H Kim
    J S Lee
    C D Kim
    S S Bae
    [J]. Oncogene, 2011, 30 : 2954 - 2963
  • [48] Shh and Akt1 signaling pathways converge through mammalian target of rapamycin (mTOR) signaling to drive the growth of BCCs
    Back, J.
    Zhu, Y.
    Tang, X.
    Athar, M.
    Kim, A. L.
    Bickers, D. R.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2011, 131 : S23 - S23
  • [49] Selective activation of Akt1 by mammalian target of rapamycin complex 2 regulates cancer cell migration, invasion, and metastasis
    Kim, E. K.
    Yun, S. J.
    Ha, J. M.
    Kim, Y. W.
    Jin, I. H.
    Yun, J.
    Shin, H. K.
    Song, S. H.
    Kim, J. H.
    Lee, J. S.
    Kim, C. D.
    Bae, S. S.
    [J]. ONCOGENE, 2011, 30 (26) : 2954 - 2963
  • [50] Erythropoietin is a novel vascular protectant through activation of Akt1 and mitochondrial modulation of cysteine proteases
    Chong, ZZ
    Kang, JQ
    Maiese, K
    [J]. CIRCULATION, 2002, 106 (23) : 2973 - 2979
12345